AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
NYSE:AMN - New York Stock Exchange, Inc. - US0017441017 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to AMN. AMN was compared to 103 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of AMN get a neutral evaluation. Nothing too spectacular is happening here. AMN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
AMN had a positive operating cash flow in the past year.
Of the past 5 years AMN 4 years were profitable.
Each year in the past 5 years AMN had a positive operating cash flow.
1.2 Ratios
AMN has a worse Return On Assets (-6.91%) than 72.82% of its industry peers.
AMN's Return On Equity of -23.13% is on the low side compared to the rest of the industry. AMN is outperformed by 66.02% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.77%, AMN is in line with its industry, outperforming 48.54% of the companies in the same industry.
AMN had an Average Return On Invested Capital over the past 3 years of 13.14%. This is above the industry average of 9.71%.
The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(3.77%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.91% | ||
| ROE | -23.13% | ||
| ROIC | 3.77% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN has a Operating Margin of 3.24%. This is comparable to the rest of the industry: AMN outperforms 54.37% of its industry peers.
AMN's Operating Margin has declined in the last couple of years.
AMN has a Gross Margin (30.15%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AMN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.15% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMN is creating some value.
AMN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMN has less shares outstanding
AMN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.38 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AMN (2.38) is comparable to the rest of the industry.
The Debt to FCF ratio of AMN is 3.85, which is a good value as it means it would take AMN, 3.85 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.85, AMN is doing good in the industry, outperforming 72.82% of the companies in the same industry.
AMN has a Debt/Equity ratio of 1.39. This is a high value indicating a heavy dependency on external financing.
AMN has a worse Debt to Equity ratio (1.39) than 67.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.39 | ||
| Debt/FCF | 3.85 | ||
| Altman-Z | 2.38 |
ROIC/WACC0.51
WACC7.45%
2.3 Liquidity
AMN has a Current Ratio of 1.08. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN's Current ratio of 1.08 is on the low side compared to the rest of the industry. AMN is outperformed by 69.90% of its industry peers.
A Quick Ratio of 1.08 indicates that AMN should not have too much problems paying its short term obligations.
The Quick ratio of AMN (1.08) is worse than 65.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -57.98% in the last year.
The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.13%.
AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-57.98%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-53.61%
Revenue 1Y (TTM)-18.13%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-16%
3.2 Future
Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-65.56%
EPS Next 2Y-34.15%
EPS Next 3Y-17.8%
EPS Next 5Y22.82%
Revenue Next Year-10.02%
Revenue Next 2Y-4.28%
Revenue Next 3Y-1%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
AMN is valuated cheaply with a Price/Earnings ratio of 7.10.
Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 96.12% of the companies listed in the same industry.
AMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.50.
With a Price/Forward Earnings ratio of 13.81, AMN is valued correctly.
Based on the Price/Forward Earnings ratio, AMN is valued a bit cheaper than 74.76% of the companies in the same industry.
AMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.1 | ||
| Fwd PE | 13.81 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 86.41% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 99.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.93 | ||
| EV/EBITDA | 6.57 |
4.3 Compensation for Growth
AMN's earnings are expected to decrease with -17.80% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)8.83
EPS Next 2Y-34.15%
EPS Next 3Y-17.8%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.82
-0.52 (-2.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners106.39%
Inst Owner Change0%
Ins Owners0.42%
Ins Owner Change4.7%
Market Cap758.71M
Analysts69.23
Price Target27.07 (36.58%)
Short Float %11.51%
Short Ratio6.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.13%
Min EPS beat(2)52.24%
Max EPS beat(2)116.02%
EPS beat(4)4
Avg EPS beat(4)50.41%
Min EPS beat(4)5.34%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)29.43%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)20.98%
Revenue beat(2)2
Avg Revenue beat(2)3.32%
Min Revenue beat(2)1.88%
Max Revenue beat(2)4.75%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.96%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.76%
Revenue beat(12)8
Avg Revenue beat(12)1.38%
Revenue beat(16)12
Avg Revenue beat(16)2.16%
PT rev (1m)0%
PT rev (3m)-15.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.74%
EPS NY rev (1m)12.88%
EPS NY rev (3m)2.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.57%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)0.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.1 | ||
| Fwd PE | 13.81 | ||
| P/S | 0.27 | ||
| P/FCF | 2.93 | ||
| P/OCF | 2.29 | ||
| P/B | 1.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.57 |
EPS(TTM)2.79
EY14.08%
EPS(NY)1.44
Fwd EY7.24%
FCF(TTM)6.77
FCFY34.13%
OCF(TTM)8.67
OCFY43.72%
SpS74.52
BVpS18.68
TBVpS-14.22
PEG (NY)N/A
PEG (5Y)8.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.91% | ||
| ROE | -23.13% | ||
| ROCE | 5.09% | ||
| ROIC | 3.77% | ||
| ROICexc | 3.89% | ||
| ROICexgc | 13.75% | ||
| OM | 3.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.15% | ||
| FCFM | 9.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexcg growth 3Y-38.44%
ROICexcg growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score3
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.39 | ||
| Debt/FCF | 3.85 | ||
| Debt/EBITDA | 3.81 | ||
| Cap/Depr | 43% | ||
| Cap/Sales | 2.55% | ||
| Interest Coverage | 1.64 | ||
| Cash Conversion | 126.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.38 |
F-Score3
WACC7.45%
ROIC/WACC0.51
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.98%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-53.61%
EPS Next Y-65.56%
EPS Next 2Y-34.15%
EPS Next 3Y-17.8%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-18.13%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-16%
Revenue Next Year-10.02%
Revenue Next 2Y-4.28%
Revenue Next 3Y-1%
Revenue Next 5Y4.4%
EBIT growth 1Y-63.46%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year95.75%
EBIT Next 3Y30.53%
EBIT Next 5YN/A
FCF growth 1Y-37.16%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-33.25%
OCF growth 3Y1.61%
OCF growth 5Y7.34%